Clinical Trials Directory

Trials / Completed

CompletedNCT06646302

Residual Inhibition of 40 Hz Burst Sound in Tinnitus Patients

Neural and Clinical Effects of 40 Hz Burst Stimulation in Tinnitus: a Four-phase Self-controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
265 (actual)
Sponsor
Eye & ENT Hospital of Fudan University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Tinnitus affects 10-15% of adults and is frequently associated with impaired quality of life, anxiety, and sleep disturbance. Conventional sound therapies based on continuous masking provide inconsistent and short-lived relief, and the neural mechanisms underlying residual inhibition (RI) remain unclear. This study aims to determine whether 40 Hz burst stimulation with high-frequency carriers can achieve longer-lasting RI than continuous sound, and to explore its underlying neural mechanisms using EEG.

Detailed description

Residual inhibition (RI) refers to the temporary reduction or disappearance of tinnitus following sound stimulation and provides an important clue for identifying patients who may benefit from acoustic therapy. However, the effects of different sound stimulation strategies on RI remain poorly understood. This study evaluates whether 40 Hz burst-modulated sound achieves stronger and longer RI compared with conventional continuous stimulation. The trial follows a four-phase design: Phase 1: Exploratory testing of burst versus continuous tones at different frequencies. Phase 2: Large-scale validation in 265 patients. Phase 3: Development of a personalized stimulation protocol using adaptive spectral optimization. Phase 4: EEG investigation of neural mechanisms, focusing on gamma oscillations and functional connectivity changes. The primary outcomes are the strength and duration of tinnitus suppression. Secondary outcomes include EEG markers such as γ-band power spectral density and phase-locking value. By combining behavioral and neurophysiological measures, this study aims to establish 40 Hz burst stimulation as a novel rhythm-based sound therapy and to provide mechanistic insights that may enable more effective, personalized tinnitus management.

Conditions

Interventions

TypeNameDescription
OTHERPersonalized 40 Hz Broadband StimulationBroadband acoustic stimulus (125 Hz-12 kHz) amplitude-modulated at 40 Hz with a 50% duty cycle. A polynomial regression and FFT-based algorithm applies individualized frequency weighting, combining population data (70%) and patient-specific responses (30%). Delivered for 60 seconds at 10 dB above the individual minimum masking level (MML).
OTHER40 Hz Pure Tone StimulationPure tone stimulus at the optimized frequency (matched to tinnitus characteristics or high-frequency carrier), amplitude-modulated at 40 Hz with a 50% duty cycle. Delivered for 60 seconds at 10 dB above MML.
OTHERContinuous Broadband NoiseContinuous broadband noise spanning 125 Hz-12 kHz without 40 Hz modulation. Delivered for 60 seconds at 10 dB above MML as an active control condition.

Timeline

Start date
2024-10-28
Primary completion
2025-07-18
Completion
2025-07-18
First posted
2024-10-17
Last updated
2025-09-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06646302. Inclusion in this directory is not an endorsement.